Genetic Engineering Advance | Gene Therapy and Clinical Applications by Diljeet Singh | Learn Smarter
K12 Students

Academics

AI-Powered learning for Grades 8–12, aligned with major Indian and international curricula.

Academics
Professionals

Professional Courses

Industry-relevant training in Business, Technology, and Design to help professionals and graduates upskill for real-world careers.

Professional Courses
Games

Interactive Games

Fun, engaging games to boost memory, math fluency, typing speed, and English skills—perfect for learners of all ages.

games
Gene Therapy and Clinical Applications

Gene therapy is utilized to rectify or substitute faulty genes in patients, employing innovative methods such as viral and non-viral delivery systems to ensure successful treatment. The chapter emphasizes the approval of several gene therapies for clinical use and addresses the essential ethical, safety, and regulatory issues that accompany this rapidly advancing field. With a focus on personalized approaches and the integration of AI in gene therapy, the future possibilities are promising.

Enroll to start learning

You’ve not yet enrolled in this course. Please enroll for free to listen to audio lessons, classroom podcasts and take mock test.

Sections

  • 3

    Gene Therapy And Clinical Applications

    This section explores gene therapy's principles, its clinical applications, and successful case studies.

  • 3.1

    Description

  • 3.2

    Learning Objectives

    This section outlines the learning objectives for understanding gene therapy and its clinical applications.

  • 3.1

    Section 1: Fundamentals Of Gene Therapy

  • 3.1.1

    Gene Therapy

    Gene therapy involves the introduction of genetic material to treat diseases, differentiating between somatic and germline types.

  • 3.1.2

    Somatic Gene Therapy

    Somatic gene therapy is a medical technique that modifies the genes in body cells to treat diseases, focusing on individual patient care without heritability.

  • 3.1.3

    Germline Gene Therapy

    Germline gene therapy involves altering genes in eggs and sperm, resulting in heritable changes in an individual’s genetic makeup.

  • 3.2

    Section 2: Gene Delivery Methods In Therapy

  • 3.2.1

    Viral Vectors

    Viral vectors are modified viruses used to deliver therapeutic genes for long-term expression in gene therapy.

  • 3.2.2

    Non-Viral Methods

    Non-viral methods of gene delivery provide alternative strategies for introducing genetic material into cells with reduced immune response.

  • 3.2.3

    Ex Vivo Gene Therapy

    Ex vivo gene therapy involves modifying cells outside the body before introducing them back into the patient for therapeutic benefits.

  • 3.2.4

    In Vivo Gene Therapy

    In Vivo gene therapy involves the direct delivery of genetic material into a patient's body to treat disease.

  • 3.3

    Section 3: Clinical Applications Of Gene Therapy

  • 3.3.1

    Leber’s Congenital Amaurosis (Lca)

    Leber’s Congenital Amaurosis (LCA) represents a significant genetic condition affecting vision, treated with gene therapy.

  • 3.3.2

    Spinal Muscular Atrophy (Sma)

    This section focuses on Spinal Muscular Atrophy and its treatment through the innovative gene therapy Zolgensma.

  • 3.3.3

    Hemophilia

    Hemophilia is a genetic disorder where blood does not clot properly, making it essential to explore gene therapy strategies for treatment.

  • 3.3.4

    Cancer (Car-T Therapy)

    CAR-T therapy is an innovative gene therapy approach that modifies a patient's T cells to target and destroy cancer cells.

  • 3.3.5

    Cystic Fibrosis

    This section discusses cystic fibrosis (CF), its underlying genetic causes, and how gene therapy aims to treat CF by targeting the CFTR gene.

  • 3.4

    Section 4: Ethical And Regulatory Aspects

  • 3.4.1

    Informed Consent

    Informed consent is a crucial component in gene therapy, requiring patients to understand the risks and objectives involved in their treatment.

  • 3.4.2

    Long-Term Safety

    Long-term safety monitoring is crucial for gene therapy to evaluate the potential long-term effects of genetic interventions.

  • 3.4.3

    Germline Editing Bans

    This section discusses the ethical implications and regulatory landscape surrounding germline editing bans in various countries.

  • 3.4.4

    Regulatory Bodies

    This section overview the essential regulatory bodies involved in gene therapy oversight.

  • 3.5

    Section 5: Emerging Trends In Clinical Gene Therapy

  • 3.5.1

    Crispr In Clinical Trials

    This section discusses the application of CRISPR technology in current clinical trials aimed at treating genetic disorders like Sickle Cell Disease and Beta Thalassemia.

  • 3.5.2

    Personalized Gene Therapies

    Personalized gene therapies utilize genomic information to tailor treatments for individuals, improving the effectiveness of gene therapy.

  • 3.5.3

    Ai-Assisted Target Discovery And Delivery Optimization

    This section discusses the role of AI in enhancing the processes involved in gene therapy, particularly focusing on target discovery and optimizing delivery systems.

  • 3.5.4

    Gene Silencing Using Sirna And Antisense Oligonucleotides

    This section discusses the mechanisms and applications of gene silencing through siRNA and antisense oligonucleotides.

  • 3.6

    Chapter Summary

    This chapter summarizes the principles, challenges, and future directions of gene therapy in treating human diseases.

Class Notes

Memorization

What we have learnt

  • Gene therapy aims to correc...
  • Viral and non-viral deliver...
  • Several gene therapies are ...

Final Test

Revision Tests